Total Payments
$50,533
2024 Payments
$2,202
Companies
18
Transactions
83
Medicare Patients
1,835
Medicare Billing
$347,925
Payment Breakdown by Category
Consulting$26,246 (51.9%)
Other$15,500 (30.7%)
Travel$5,330 (10.5%)
Food & Beverage$3,361 (6.7%)
Education$96.09 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,246 | 14 | 51.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,500 | 4 | 24.7% |
| Travel and Lodging | $5,330 | 19 | 10.5% |
| Food and Beverage | $3,361 | 42 | 6.7% |
| Honoraria | $3,000 | 1 | 5.9% |
| Education | $96.09 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $19,501 | 26 | $0 (2018) |
| Merrimack Pharmaceuticals, Inc. | $6,044 | 7 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $6,006 | 9 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $5,052 | 6 | $0 (2024) |
| Celgene Corporation | $3,275 | 8 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $3,203 | 8 | $0 (2017) |
| ARRAY BIOPHARMA INC | $3,000 | 1 | $0 (2020) |
| Daiichi Sankyo Inc. | $2,220 | 1 | $0 (2020) |
| Taiho Oncology, Inc. | $1,163 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $341.11 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,202 | 2 | AstraZeneca Pharmaceuticals LP ($2,202) |
| 2020 | $6,120 | 3 | ARRAY BIOPHARMA INC ($3,000) |
| 2019 | $669.61 | 7 | Merck Sharp & Dohme Corporation ($323.71) |
| 2018 | $9,789 | 20 | Bayer HealthCare Pharmaceuticals Inc. ($5,106) |
| 2017 | $31,752 | 51 | Ipsen Biopharmaceuticals, Inc ($15,199) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,081.25 | General |
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Oncology | ||||||
| 11/06/2020 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 09/29/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| Category: Oncology | ||||||
| 11/12/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $92.24 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $108.81 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $125.94 | General |
| Category: Virology | ||||||
| 06/11/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $100.81 | General |
| Category: Oncology | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $119.15 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $109.03 | General |
| 10/29/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2018 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $95.70 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2018 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 08/17/2018 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| Category: Oncology | ||||||
| 08/17/2018 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Travel and Lodging | In-kind items and services | $383.13 | General |
| Category: Oncology | ||||||
| 08/17/2018 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $154.86 | General |
| Category: Oncology | ||||||
| 08/14/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $85.72 | General |
| Category: Oncology | ||||||
| 06/19/2018 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Oncology | ||||||
| 06/12/2018 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $96.33 | General |
| Category: Oncology | ||||||
| 05/24/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 05/11/2018 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/11/2018 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $53.95 | General |
| 05/11/2018 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $52.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 516 | 1,154 | $315,157 | $99,622 |
| 2022 | 7 | 403 | 912 | $245,571 | $83,209 |
| 2021 | 9 | 474 | 1,053 | $271,295 | $97,222 |
| 2020 | 10 | 442 | 901 | $204,417 | $67,872 |
Total Patients
1,835
Total Services
4,020
Medicare Billing
$347,925
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 522 | $135,198 | $39,505 | 29.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 86 | 231 | $57,288 | $21,969 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 137 | $50,542 | $15,003 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 76 | $33,212 | $10,831 | 32.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $18,135 | $5,704 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 86 | $15,308 | $4,566 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 15 | $2,520 | $991.65 | 39.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $2,184 | $807.60 | 37.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 35 | $770.00 | $244.63 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 423 | $99,405 | $32,310 | 32.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 74 | 191 | $46,031 | $16,316 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 143 | $47,710 | $16,228 | 34.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 64 | $27,968 | $10,475 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $14,880 | $4,864 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 46 | $7,406 | $2,265 | 30.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 13 | $2,171 | $751.75 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 412 | $92,288 | $32,023 | 34.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 73 | 173 | $54,891 | $21,088 | 38.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 80 | 240 | $57,840 | $20,377 | 35.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 63 | $27,603 | $10,381 | 37.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 37 | 37 | $16,576 | $5,876 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 64 | $9,792 | $2,964 | 30.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 26 | 31 | $5,177 | $1,898 | 36.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,600 | $1,393 | 38.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 21 | $3,528 | $1,221 | 34.6% |
About Edward James, M.D.,
Edward James, M.D., is a Hematology & Oncology healthcare provider based in Park Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548442007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward James, M.D., has received a total of $50,533 in payments from pharmaceutical and medical device companies, with $2,202 received in 2024. These payments were reported across 83 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($26,246).
As a Medicare-enrolled provider, James has provided services to 1,835 Medicare beneficiaries, totaling 4,020 services with total Medicare billing of $347,925. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Park Ridge, IL
- Active Since 11/27/2007
- Last Updated 07/02/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1548442007
Products in Payments
- Onivyde (Drug) $13,619
- ONIVYDE (Drug) $6,044
- Somatuline Depot 120mg-.5ml (Drug) $5,139
- Abraxane (Drug) $3,275
- OPDIVO (Biological) $3,203
- BRAFTOVI (Drug) $3,000
- Enhertu (Drug) $2,220
- Stivarga (Drug) $1,800
- Lonsurf (Drug) $1,163
- KEYTRUDA (Biological) $232.08
- TAGRISSO (Drug) $203.22
- Venclexta (Drug) $125.94
- IMFINZI (Biological) $121.13
- LIBTAYO (Biological) $119.15
- Imbruvica (Drug) $100.81
- CALQUENCE (Drug) $96.33
- AKYNZEO (Drug) $95.70
- Vectibix (Biological) $92.38
- Rubraca (Drug) $86.91
- NINLARO (Drug) $85.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Park Ridge
Mrs. Sigrun Hallmeyer, Md, MD
Hematology & Oncology — Payments: $200,542
Hematology & Oncology $200,542
Mr. Jon Richards, M.d, M.D
Hematology & Oncology — Payments: $76,876
Hematology & Oncology $76,876
Dr. Jason Macklis, M.d, M.D
Hematology & Oncology — Payments: $14,505
Hematology & Oncology $14,505
Mrs. Pamela Kaiser, M.d, M.D
Hematology & Oncology — Payments: $13,644
Hematology & Oncology $13,644
Mr. Jacob Bitran, M.d, M.D
Hematology & Oncology — Payments: $5,156
Hematology & Oncology $5,156
Angel Galvez, M.d, M.D
Hematology & Oncology — Payments: $4,513
Hematology & Oncology $4,513